Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry D Hinds

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
International Journal of Molecular Sciences|December 17, 2020
Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver DiseaseDavid E Stec, Terry D Hinds
The International Journal of Biochemistry & Cell Biology|October 24, 2007
Protein phosphatase 5Terry D Hinds, Edwin R Sánchez
Current Hypertension Reports|October 11, 2019
Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in HealthTerry D Hinds, David E Stec
Cancer Cell & Microenvironment|July 29, 2016
Sweet-P inhibition of glucocorticoid receptor β as a potential cancer therapyAssumpta C Nwaneri, Lucien McBeth, Terry D Hinds
Hormones & Cancer|July 23, 2016
Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor SignalingAssumpta C Nwaneri, Lucien McBeth, Terry D Hinds
Oncotarget|October 1, 2016
Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?Vikram L Sundararaghavan, Puneet Sindhwani, Terry D Hinds
PPAR Research|March 29, 2017
Deciphering the Roles of Thiazolidinediones and PPAR<b>γ</b> in Bladder CancerMelody Chiu, Lucien McBeth, Puneet Sindhwani, et al.
Trends in Endocrinology and Metabolism: TEM|June 4, 2026
Glucocorticoid resistance-induced inflammation drives cardiovascular-kidney-metabolic (CKM) syndrome pathophysiologyGenesee J Martinez, David E Stec, Terry D Hinds
International Journal of Endocrinology|September 9, 2015
Involvement of the Androgen and Glucocorticoid Receptors in Bladder CancerLucien McBeth, Maria Grabnar, Steven Selman, et al.
Current Hypertension Reports|May 16, 2023
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular DiseaseOlufunto O Badmus, Terry D Hinds, David E Stec
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Molecular Sciences|December 17, 2020
Natural Product Heme Oxygenase Inducers as Treatment for Nonalcoholic Fatty Liver DiseaseDavid E Stec, Terry D Hinds
The International Journal of Biochemistry & Cell Biology|October 24, 2007
Protein phosphatase 5Terry D Hinds, Edwin R Sánchez
Current Hypertension Reports|October 11, 2019
Bilirubin Safeguards Cardiorenal and Metabolic Diseases: a Protective Role in HealthTerry D Hinds, David E Stec
Cancer Cell & Microenvironment|July 29, 2016
Sweet-P inhibition of glucocorticoid receptor β as a potential cancer therapyAssumpta C Nwaneri, Lucien McBeth, Terry D Hinds
Hormones & Cancer|July 23, 2016
Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor SignalingAssumpta C Nwaneri, Lucien McBeth, Terry D Hinds
Oncotarget|October 1, 2016
Glucuronidation and UGT isozymes in bladder: new targets for the treatment of uroepithelial carcinomas?Vikram L Sundararaghavan, Puneet Sindhwani, Terry D Hinds
PPAR Research|March 29, 2017
Deciphering the Roles of Thiazolidinediones and PPAR<b>γ</b> in Bladder CancerMelody Chiu, Lucien McBeth, Puneet Sindhwani, et al.
Trends in Endocrinology and Metabolism: TEM|June 4, 2026
Glucocorticoid resistance-induced inflammation drives cardiovascular-kidney-metabolic (CKM) syndrome pathophysiologyGenesee J Martinez, David E Stec, Terry D Hinds
International Journal of Endocrinology|September 9, 2015
Involvement of the Androgen and Glucocorticoid Receptors in Bladder CancerLucien McBeth, Maria Grabnar, Steven Selman, et al.
Current Hypertension Reports|May 16, 2023
Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular DiseaseOlufunto O Badmus, Terry D Hinds, David E Stec
Pageof 11